#IAS25: As researchers come together for HIV conference, few biotechs can stay the coursenews2025-07-11T12:00:58+00:00July 11th, 2025|Endpoints News|
FDA hands Capricor a CRL for its Duchenne cell therapy news2025-07-11T11:26:27+00:00July 11th, 2025|Endpoints News|
FDA approves Moderna’s Covid shot for at-risk kidsnews2025-07-10T19:41:53+00:00July 10th, 2025|Endpoints News|
Jazz taps current COO Renée Galá to replace CEO and co-founder Bruce Cozaddnews2025-07-10T16:51:53+00:00July 10th, 2025|Endpoints News|
Soleno’s first wave of rare disease drug sales beats expectationsnews2025-07-10T14:07:33+00:00July 10th, 2025|Endpoints News|
J&J prevails in schizophrenia drug patent spat against Tevanews2025-07-09T17:58:10+00:00July 9th, 2025|Endpoints News|
CoRegen closes $93M financing round to enter the clinicnews2025-07-09T17:37:07+00:00July 9th, 2025|Endpoints News|
Biopharma pay analysis: Highest-paying drugmakers of 2024news2025-07-09T14:00:41+00:00July 9th, 2025|Endpoints News|
Trump’s CDC nominee Monarez advances to full Senatenews2025-07-09T13:48:26+00:00July 9th, 2025|Endpoints News|
Merck to buy respiratory drugmaker Verona Pharma for $10Bnews2025-07-09T11:01:58+00:00July 9th, 2025|Endpoints News|
